Journal: Molecular Therapy Oncology
Article Title: Vinorelbine enhances the efficacy of oncolytic vaccinia virus in a preclinical model of ovarian high-grade serous carcinoma
doi: 10.1016/j.omton.2025.201105
Figure Lengend Snippet: Vaccinia and vinorelbine induces apoptotic ID8 Trp53 −/− cell death (A) Representative phase contrast images of ID8 Trp53 −/− cells after 16 h treatment with DMSO or vinorelbine (1 μM). Scale bars, 150 μm. (B) Immunofluorescent images of microtubule cytoskeleton (tubulin, green) in ID8 Trp53 −/− cells treated with DMSO or vinorelbine with or without infection with ΔVFTK (vaccinia, red). DAPI (blue) was used to stain nuclei and cytoplasmic viral factories. Yellow arrows indicate fragmented nuclei. Scale bars, 10 μM. (C) Immunoblot of the indicated viral proteins following infection for 4 or 8 h with ΔVFTK-NG following 16 h pre-treatment with DMSO or vinorelbine. Vinculin is the cell loading control. (D) Immunoblot examining the levels of LC3 lipidation (LC3-II) and p62 in ID8 Tr53 −/− cells pretreated with vinorelbine or DMSO for 8 h and infected with ΔVFTK-NG for 24 h. Chloroquine (Clq) treatment for 3 h represents the positive control. (E) Immunoblot examining the levels pf MLKL phosphorylation and PARP cleavage in ID8 Tr53 −/− cells pretreated with vinorelbine or DMSO for 8 h and infected with ΔVFTK-NG for 24 h. Staurosporine (S) (8 h) and 0.1% hydrogen peroxide (H 2 O 2 ) combined with Z-VAD (two hours) represent positive controls for apoptosis and necroptosis, respectively. (F) Immunoblot examining the levels of cleaved caspase-8, caspase-3, and PARP in ID8 Tr53 −/− cells treated with vinorelbine 8 h before or after infection with ΔVFTK-NG for 24 h. In (D, E, and F), H5 and GAPDH represent the viral and cell loading controls, respectively. For all experiments, uninfected DMSO-treated cells (UI) were the negative control. Asterisks (∗) indicate non-specific bands. Immunoblot experiments were repeated three times, and representative examples are shown. (G) Median percentage cell confluency over time for the indicated conditions. Cells were treated with the indicated compounds or ΔVFTK-NG at 16 h post-seeding (dashed line numbered 1). The dashed line numbered 2 (24 h after cell seeding) represents the time of addition of either vinorelbine or ΔVFTK-NG for the combination groups.
Article Snippet: Primary antibodies used were F12 (1:4,000, ), F13 (1:6,000, ), H5 (1:10,000, ), GRB2 (1:1,000, Santa Cruz, Dallas, Texas, #sc-255), Vinculin (1:10,000, Sigma-Aldrich, #V9264), GAPDH (1:1,000, Santa Cruz, #sc-32233), PARP (1:1,000, Cell Signaling, Danvers, Massachusetts, #9542), cleaved caspase-8 (1:1,000, Cell Signaling, #8592), cleaved caspase-3 (1:1,000, Cell Signaling, #9664), LC3-B (1:1,000, Abcam [#ab48394], Cambridge, UK), p62/SQSTM1 (1:1,000, Novus Biologicals, Centennial, Colorado, #NBP1-42822), and NeonGreen (1:1,000, Cell Signaling, #41236).
Techniques: Infection, Staining, Western Blot, Control, Positive Control, Phospho-proteomics, Negative Control